Search Results
Sep 07, 2026, 00:38 ET Une vie inspirée par l'IA : TCL redéfinit le quotidien au salon IFA 2026
qu'à l'autre extrémité de la gamme d'écrans portables, les lunettes de réalité augmentée RayNeo GT Max et les lunettes intelligentes RayNeo iO explorent de nouvelles formes d'objets connectés et d'interaction quotidienne visuelle avec l'IA, et que le TCL Tbot transforme les montres
More news about: TCL
Sep 04, 2026, 12:45 ET Zainspirowane życiem, napędzane przez AI: TCL na nowo definiuje codzienne doświadczenia podczas IFA 2026
na ekran o przekątnej 12,2 cala. Na drugim krańcu spektrum urządzeń przenośnych okulary AR RayNeo GT Max oraz inteligentne okulary RayNeo iO eksplorują nowe formy korzystania z urządzeń noszonych i codziennej interakcji z AI, natomiast TCL Tbot rozszerza funkcję dziecięcych smartwatchy
More news about: TCL
Sep 04, 2026, 09:46 ET Lấy cảm hứng từ cuộc sống, được hỗ trợ bởi AI: TCL định nghĩa lại trải nghiệm hằng ngày tại IFA 2026
trên giấy lên màn hình 12,2 inch, trong khi ở đầu còn lại của phổ thiết bị hiển thị di động, kính AR RayNeo GT Max và kính thông minh RayNeo iO khám phá những hình thức mới của trải nghiệm xem trên thiết bị đeo và tương tác AI hằng ngày, trong khi TCL Tbot mở rộng vai trò của đồng hồ
More news about: TCL
Sep 04, 2026, 09:17 ET RayNeo Showcases Next-Generation Cinematic AR and AI Smart Glasses at IFA 2026 with Dolby and Bang & Olufsen
Head of Consumer Electronics, Bang & OlufsenRayNeo iO: AI Assistance in the User's Line of SightMedia also tested the RayNeo iO Smart Glasses in real-time productivity scenarios. Weighing just 33 grams, iO is designed around a discreet heads-up display that presents useful
More news about: RayNeo
Sep 04, 2026, 09:07 ET RayNeo Showcases Next-Generation Cinematic AR and AI Smart Glasses at IFA 2026 with Dolby and Bang & Olufsen
Head of Consumer Electronics, Bang & OlufsenRayNeo iO: AI Assistance in the User's Line of SightMedia also tested the RayNeo iO Smart Glasses in real-time productivity scenarios. Weighing just 33 grams, iO is designed around a discreet heads-up display that presents useful
More news about: RayNeo
Sep 04, 2026, 08:35 ET Inspirado en la vida, impulsado por la IA: TCL redefine las experiencias cotidianas en IFA 2026
que en el otro extremo del espectro de pantallas portátiles, las gafas de realidad aumentada RayNeo GT Max y las gafas inteligentes RayNeo iO exploran nuevas formas de visualización portátil e interacción cotidiana con la IA, y TCL Tbot amplía las funciones de los relojes inteligentes
More news about: TCL
Sep 04, 2026, 05:36 ET Kehidupan yang Didukung AI: TCL Hadirkan Inovasi AI dalam Kehidupan Sehari-hari di IFA 2026
NXTPAPER menghadirkan tampilan yang menyerupai kertas pada layar berukuran 12,2 inci. Sementara itu, RayNeo GT Max AR Glasses dan RayNeo iO Smart Glasses menawarkan cara berbeda untuk menikmati konten melalui perangkat wearable, serta menghadirkan fitur interaksi berbasis AI dalam
More news about: TCL
Sep 04, 2026, 05:34 ET 삶에서 얻은 영감, AI로 구동되다: TCL, IFA 2026에서 일상 경험 재정의
준다. 태블릿 사용자를 위한 TCL TAB A1 Plus NXTPAPER는 이러한 종이 질감의 시청 경험을 12.2인치 디스플레이로 확장한다. 휴대형 디스플레이의 또 다른 영역에서는 RayNeo GT Max AR Glasses와 RayNeo iO Smart Glasses가 웨어러블 시청 및 일상적 AI 상호작용의 새로운 형태를 제시하며, TCL Tbot은 어린이용 스마트워치의 역할을 야외 안전 지킴이에서 인터랙티브 데스크톱 컴패니언으로 확장한다.TCL은 제품 시연을 넘어 업계
More news about: TCL
Sep 04, 2026, 03:26 ET Inspirováno životem, poháněno umělou inteligencí: TCL na veletrhu IFA 2026 nově definuje každodenní zážitky
připomínající papír na 12,2palcovém displeji. Na opačném konci spektra přenosných displejů zkoumají brýle RayNeo GT Max AR a chytré brýle RayNeo iO nové podoby nositelného zobrazování a každodenní interakce s umělou inteligencí a TCL Tbot posouvá dětské chytré hodinky od strážce bezpečí
More news about: TCL
Sep 03, 2026, 23:32 ET Inspirado en la vida, impulsado por la IA: TCL redefine las experiencias cotidianas en la IFA 2026
que, en el otro extremo del espectro de pantallas portátiles, las gafas de realidad aumentada RayNeo GT Max y las gafas inteligentes RayNeo iO exploran nuevas formas de visualización con dispositivos wearables y de interacción cotidiana con la IA, y el TCL Tbot amplía las funciones
More news about: TCL
Sep 03, 2026, 12:45 ET Inspired by Life, Powered by AI: TCL Redefines Everyday Experiences at IFA 2026
paper-like viewing experience to a 12.2-inch display, while on the other end of the portable display spectrum, RayNeo GT Max AR Glasses and RayNeo iO Smart Glasses explore new forms of wearable viewing and everyday AI interaction, and TCL Tbot extends children's smartwatches from outdoor
More news about: TCL
Sep 03, 2026, 12:29 ET Inspired by Life, Powered by AI: TCL Redefines Everyday Experiences at IFA 2026
paper-like viewing experience to a 12.2-inch display, while on the other end of the portable display spectrum, RayNeo GT Max AR Glasses and RayNeo iO Smart Glasses explore new forms of wearable viewing and everyday AI interaction, and TCL Tbot extends children's smartwatches from outdoor
More news about: TCL
Sep 03, 2026, 00:02 ET Eluvio Unveils Industry-First: Inline, Open-Model Video AI and Agentic Orchestration at IBC 2026
Grand Prize, the Hollywood Professional Association Engineering Excellence Award, and other industry honors.@EluvioInc | linkedin.com/company/eluv-io
More news about: Eluvio, Inc.
Sep 03, 2026, 00:01 ET Eluvio Showcases New Advanced Features in Global Broadcast Fabric for Zero-Copy Broadcast Distribution, D2C OTT Streaming & Monetization, and Inline AI Video Intelligence at IBC 2026
linkedin.com/company/eluv-io
More news about: Eluvio, Inc.
Sep 02, 2026, 08:30 ET Caris Life Sciences to Present New Research Advancing Precision Oncology at the IASLC 2026 World Conference on Lung Cancer
fewer CD8+ T-cells and other adaptive immune cells, suggesting a less favorable immune microenvironment.Prevalence of Immunotherapy (IO) Biomarkers, Tumor Microenvironment (TME) Composition and Survival by Race/Ethnicity in NSCLCSession: MO13 – Global Challenges and
More news about: Caris Life Sciences
Sep 01, 2026, 09:00 ET TUMI PRESENTA LA COLLEZIONE AUTUNNO/INVERNO 2026 ATTRAVERSO UNA CAMPAGNA CHE SEGUE IL PERCORSO DI LANDO NORRIS VERSO NUOVE VETTE
stagione.« C'è sempre un'altra vetta da raggiungere, un altro obiettivo da perseguire » dichiara Lando Norris. « Questa ambizione è un valore che TUMI e io condividiamo, e la ritrovo in ogni borsa TUMI che porto con me. »L'ultima generazione della collezione Alpha, lanciata la scorsa primavera,
More news about: Tumi, Inc.
Sep 01, 2026, 08:00 ET Roland DG Expands Industrial Direct-to-Object Printing Portfolio with Launch of VersaObject IO-300 and RC-300 Series
the VersaObject IO-300 and RC-300 Series empower businesses to produce exactly what customers need, when they need it.The VersaObject IO-300 and RC-300 Series printers are available now through Roland DG authorized partners worldwide. To learn more about the VersaObject IO-300 industrial
More news about: Roland DGA
Sep 01, 2026, 03:30 ET Amber Premium 正式轉型為 AMBR，專注為金融、企業與增長領域打造專屬 AI 智能體
www.ambr.io 或追蹤 LinkedIn 官方帳號 @AMBR_io。關於 AmbreAmbre 是 AMBR 的旗艦個人理財 AI 智能體，整合用戶跨帳戶及跨資產類別的投資組合、興趣及財務背景，從大量市場訊號中篩選真正相關的資訊，並把對話轉化為持續監察及可執行任務，協助用戶更清晰地將資訊轉化為行動。如欲了解更多，請瀏覽：
More news about: AMBR
Sep 01, 2026, 03:30 ET Amber Premium Transforms into AMBR, Dedicated to Building Specialized AI Agents for Finance, Enterprise, and Growth
www.ambr.io or @AMBR_io on LinkedIn.About AmbreAmbre is AMBR's flagship AI agent for personal finance. It brings together a user's financial portfolio
More news about: AMBR
Sep 01, 2026, 00:01 ET Eluvio to Power Pasifika+: New OTT TV Streaming Service to Reach Consumers Throughout the Pacific and Across the Globe
Seicon Grand Prize, Hollywood Professional Association Engineering Excellence Award, and other industry honors. @EluvioInc | linkedin.com/company/eluv-ioAbout Pacific Cooperation Broadcasting Limited (PCBL)Pacific Cooperation Broadcasting Limited (PCBL) was established in
More news about: Eluvio, Inc.
Aug 31, 2026, 08:22 ET CStone 2026 Interim Results: Accelerating Pipeline 2.0 Execution and Sustained Global Commercial Momentum
91.7%.Monotherapy efficacy in Immunotherapy (IO)-pretreated NSCLC and IO-nonresponsive "cold tumors" further validates CTLA-4 activity and efficacy.In second-line NSCLC patients (all previously treated with IO plus chemotherapy), CS2009 monotherapy
More news about: CStone Pharmaceuticals
Aug 31, 2026, 00:02 ET Eluvio Tapped for Cricket TV: New Direct-to-Consumer Streaming Service for Live and Archive Coverage to Fans Across the Globe
the Hollywood Professional Association Engineering Excellence Award, and other industry honors. On X: @EluvioInc | LinkedIn: linkedin.com/company/eluv-ioAbout Cricket AustraliaCricket Australia is the national governing body for the sport of cricket in Australia, responsible
More news about: Eluvio, Inc.
Aug 27, 2026, 22:44 ET Akeso 2026 Interim Results: Strong Commercialization Momentum; IO2.0+ Global Strategy Redefining Clinical Standards; Bispecific Advancement in ADC, I&I and Alzheimer's
beyond.IO2.0 Global Strategy Advances Following the approvals of ivonescimab and cadonilimab - two first-in-class immuno-oncology (IO) cornerstone therapies - Akeso has continued to advance the Company's global IO2.0+ strategy. The Company is building a bispecific antibody-based IO therapeutic
More news about: Akeso, Inc.
Aug 27, 2026, 10:15 ET CStone 2026 Interim Results: Accelerating Pipeline 2.0 Execution and Sustained Global Commercial Momentum
91.7%.Monotherapy efficacy in Immunotherapy (IO)-pretreated NSCLC and IO-nonresponsive "cold tumors" further validates CTLA-4 activity and efficacyIn second-line NSCLC patients (all previously treated with IO plus chemotherapy), CS2009 monotherapy
More news about: CStone Pharmaceuticals
Aug 26, 2026, 10:41 ET Oncolytic Virus Cancer Therapy Market Expected to Expand Rapidly During the Forecast Period (2026-2036) Amid Rising Investments in Next-Generation Cancer Treatments| DelveInsight
disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key melanoma companies including IO Biotech, Merck Sharp & Dohme, Eisai, Regeneron Pharmaceuticals, Iovance Biotherapeutics, Highlight Therapeutics, Linnaeus Therapeutics, Spring Bank
More news about: DelveInsight Business Research, LLP